Badgley Phelps Wealth Managers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Badgley Phelps Wealth Managers's BMY Position: Q2 2026 in Review
Badgley Phelps Wealth Managers reduced its Bristol-Myers Squibb (BMY) stake by 3.9% in Q2 2026, selling an estimated $61.3K and leaving 26,049 shares worth $1.5M. The position accounts for 0.03% of the portfolio, ranked #177.
Badgley Phelps Wealth Managers first reported a position in BMY in Q3 2021 and has held it in 20 quarters since. The position peaked at $19.7M in Q2 2022. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Badgley Phelps Wealth Managers held 26,049 shares of Bristol-Myers Squibb worth $1.5M as of Q2 2026.
- Badgley Phelps Wealth Managers sold 1,068 Bristol-Myers Squibb shares in Q2 2026, an estimated $61.3K.
- Bristol-Myers Squibb made up 0.03% of Badgley Phelps Wealth Managers's portfolio in Q2 2026, its #177 holding.
- Badgley Phelps Wealth Managers first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 20 quarters since.
- Badgley Phelps Wealth Managers's Bristol-Myers Squibb position peaked at $19.7M in Q2 2022.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Badgley Phelps Wealth Managers's 13F filing for Q2 2026, filed 31 Jul 2026.